lanreotide (Somatuline)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for lanreotide (Somatuline), covering 2017-01-26 to 2017-01-26. Get the full timeline:
Most recent: Clinical Trial Update: Treatment of Acromegaly With Somatostatin Analogs: GH vs. IGF-I as Primary Biochemical Target [Phase 4]